Re: To good to be true?
|
5
|
Resverlogix Corp.
|
Nov 01, 2021 07:11AM
|
Cystic Fibrosis breakthrough
|
5
|
Resverlogix Corp.
|
Nov 04, 2019 07:08PM
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
5
|
Resverlogix Corp.
|
Aug 29, 2023 06:49PM
|
Re: The Old Boy Who Cried Wolf
|
5
|
Resverlogix Corp.
|
Sep 19, 2020 08:47PM
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 22, 2022 08:45PM
|
The crick didn’t rise, here’s the presentation, finally!
|
5
|
Zenith Epigenetics
|
Oct 27, 2023 05:31PM
|
Re: I have not....
|
5
|
Resverlogix Corp.
|
Dec 12, 2019 04:36PM
|
Zenith News
|
5
|
Zenith Epigenetics
|
Sep 21, 2021 08:13AM
|
Re: Objectivity requires facts....we don't have them all yet
|
5
|
Resverlogix Corp.
|
May 15, 2019 11:31PM
|
Re: Time keeps ticking
|
5
|
Resverlogix Corp.
|
Nov 18, 2021 08:22PM
|
Re: ... IT'S ABOUT TIME...!!!!!!!!!!!
|
5
|
Resverlogix Corp.
|
Nov 23, 2017 11:32AM
|
Re: Happy New Years
|
6
|
Resverlogix Corp.
|
Dec 30, 2023 05:35PM
|
For what it’s worth
|
6
|
Zenith Epigenetics
|
Jul 19, 2023 10:06AM
|
New RVX Tweet
|
6
|
Resverlogix Corp.
|
Jul 28, 2020 03:46PM
|
Re: Video presentation from August 25, 2021
|
6
|
Resverlogix Corp.
|
Aug 31, 2021 08:13PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 26, 2022 02:43PM
|
Re: Video presentation from August 25, 2021
|
6
|
Resverlogix Corp.
|
Sep 01, 2021 10:09AM
|
Re: Round one
|
6
|
Resverlogix Corp.
|
Jan 28, 2022 06:28AM
|
Re: New Share Price Contest update to Oct 24th
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 08:41PM
|
Re: COVID 19 / varients
|
7
|
Resverlogix Corp.
|
Apr 10, 2022 04:44PM
|